
BKV Valuation
BKV Corp
- Overview
- Forecast
- Valuation
- Earnings
BKV Relative Valuation
BKV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BKV is overvalued; if below, it's undervalued.
Historical Valuation
BKV Corp (BKV) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 39.27. The fair price of BKV Corp (BKV) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:24.33
Fair
19.26
PE
1Y
3Y
5Y
Trailing
Forward
5.05
EV/EBITDA
BKV Corp. (BKV) has a current EV/EBITDA of 5.05. The 5-year average EV/EBITDA is 6.05. The thresholds are as follows: Strongly Undervalued below 3.18, Undervalued between 3.18 and 4.61, Fairly Valued between 7.48 and 4.61, Overvalued between 7.48 and 8.91, and Strongly Overvalued above 8.91. The current Forward EV/EBITDA of 5.05 falls within the Historic Trend Line -Fairly Valued range.
11.20
EV/EBIT
BKV Corp. (BKV) has a current EV/EBIT of 11.20. The 5-year average EV/EBIT is 2.30. The thresholds are as follows: Strongly Undervalued below -304.12, Undervalued between -304.12 and -150.91, Fairly Valued between 155.50 and -150.91, Overvalued between 155.50 and 308.71, and Strongly Overvalued above 308.71. The current Forward EV/EBIT of 11.20 falls within the Historic Trend Line -Fairly Valued range.
1.95
PS
BKV Corp. (BKV) has a current PS of 1.95. The 5-year average PS is 2.02. The thresholds are as follows: Strongly Undervalued below 1.42, Undervalued between 1.42 and 1.72, Fairly Valued between 2.32 and 1.72, Overvalued between 2.32 and 2.62, and Strongly Overvalued above 2.62. The current Forward PS of 1.95 falls within the Historic Trend Line -Fairly Valued range.
5.34
P/OCF
BKV Corp. (BKV) has a current P/OCF of 5.34. The 5-year average P/OCF is 5.70. The thresholds are as follows: Strongly Undervalued below 3.17, Undervalued between 3.17 and 4.44, Fairly Valued between 6.97 and 4.44, Overvalued between 6.97 and 8.24, and Strongly Overvalued above 8.24. The current Forward P/OCF of 5.34 falls within the Historic Trend Line -Fairly Valued range.
-58.92
P/FCF
BKV Corp. (BKV) has a current P/FCF of -58.92. The 5-year average P/FCF is -85.40. The thresholds are as follows: Strongly Undervalued below -750.63, Undervalued between -750.63 and -418.02, Fairly Valued between 247.21 and -418.02, Overvalued between 247.21 and 579.82, and Strongly Overvalued above 579.82. The current Forward P/FCF of -58.92 falls within the Historic Trend Line -Fairly Valued range.
BKV Corp (BKV) has a current Price-to-Book (P/B) ratio of 1.29. Compared to its 3-year average P/B ratio of 1.15 , the current P/B ratio is approximately 12.81% higher. Relative to its 5-year average P/B ratio of 1.15, the current P/B ratio is about 12.81% higher. BKV Corp (BKV) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -0.11%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -0.11% , the current FCF yield is about -100.00% lower.
1.29
P/B
Median3y
1.15
Median5y
1.15
0.34
FCF Yield
Median3y
-0.11
Median5y
-0.11
Competitors Valuation Multiple
The average P/S ratio for BKV's competitors is , providing a benchmark for relative valuation. BKV Corp Corp (BKV) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 52.50%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BKV increased by 34.87% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -34.67 to -103.12.
The secondary factor is the Revenue Growth, contributed 52.50%to the performance.
Overall, the performance of BKV in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

CLOV
Clover Health Investments Corp
2.780
USD
+2.96%

MXL
Maxlinear Inc
16.230
USD
+4.11%

SLNO
Soleno Therapeutics Inc
62.740
USD
+1.01%

ENLT
Enlight Renewable Energy Ltd
33.130
USD
+4.68%

UFPT
UFP Technologies Inc
196.410
USD
-0.29%

OSW
Onespaworld Holdings Ltd
21.260
USD
+0.38%

LBTYA
Liberty Global Ltd
11.270
USD
-0.92%

PRM
Perimeter Solutions Inc
22.290
USD
+0.45%

BTE
Baytex Energy Corp
2.560
USD
+0.79%

OFG
OFG Bancorp
42.650
USD
+0.88%
FAQ

Is BKV Corp (BKV) currently overvalued or undervalued?
BKV Corp (BKV) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 39.27. The fair price of BKV Corp (BKV) is between NaN to NaN according to relative valuation methord.

What is BKV Corp (BKV) fair value?

How does BKV's valuation metrics compare to the industry average?

What is the current P/B ratio for BKV Corp (BKV) as of Oct 08 2025?

What is the current FCF Yield for BKV Corp (BKV) as of Oct 08 2025?

What is the current Forward P/E ratio for BKV Corp (BKV) as of Oct 08 2025?
